Call the freephone number: 08082502781
New Treatments for Memory Loss & Alzheimer’s disease
Our team of experts offer trailblazing volunteers the opportunity to access new drugs designed to prevent the progression of memory impairment.
Finding a Cure for Alzheimer’s disease
Led by Dr Emer MacSweeney, an international expert in the field of Alzheimer’s research, we are passionate about finding a cure for Alzheimer’s disease.
According to the Alzheimer’s Society over 1 million people in the UK will have a diagnosis of dementia by 2025. By 2051 this number will exceed 2 million.
On a global scale, by 2030 it’s estimated that 82 million people will be suffering from dementia.
Alzheimer’s is the most common cause of dementia and is an unacceptable problem Dr Emer MacSweeney CEO & Medical Director
One Clinical Trial, One Life-Changing Opportunity
However, despite the international impact of the disease, there is indeed hope available for people experiencing memory impairment.
Because the death of brain cells in Alzheimer’s is currently unstoppable, the only medications available to be prescribed are ‘symptomatic’.
These medications manage only the symptoms of dementia, as opposed to delaying its progression.
Symptomatic drugs work to help the dying brain cells function better. However, as the disease progresses more and more brain cells die, leading to a greater decline in cognitive functioning.
Dr Emer MacSweeney, Medical Director of Re:Cognition Health talks clinical trials with Primal Cure
New Alzheimer’s Disease Treatments
The fight against Alzheimer’s disease is spearheaded by international clinical trials that provide early access to ‘disease-modifying’ Alzheimer’s treatments.
These drugs aim to keep the brain cells alive in order to reduce the progression of memory impairment. There are lots of studies open across the world investigating the effectiveness of new medications. To find out which study might be right for you or somebody you know, speak to a specialist today
Disease-modifying treatments work to reduce the levels of B amyloid & Tau Protein in the brain and to alter genetic and inflammatory markers.
These medications are believed to be much more effective than the current medications and are available as part of the clinical trials at our clinics.
Signs you, a friend or a loved one could be experiencing memory problems
Often it’s difficult to know whether or not memory issues are ‘normal’ or a sign of something more concerning, like mild cognitive impairment.
Regularly forgetting keys, the reason for going into a room, or having to read something over again, are all signs of being ‘absent-minded’. Research suggests that such characteristics are strongly linked to symptoms of anxiety, depression and stress.
Like many other conditions, prevention is better than cure and the earlier you start employing lifestyle changes, the better for your brain. Learn more about a new prevention study
If you, or someone you know, answer yes to any of the following examples, we’d recommend getting in touch by clicking the blue button below
- Asking the same question several times a day
- Unknowingly telling the same story or anecdote
- Forgetting details of conversations and recent events
- Losing your way in familiar environments
- Trouble remembering appointments
Four Re:Cognition Health Clinics, One International Community Of Experts
Like all research studies, the protocols for clinical trials are the same across the world. This means that a volunteer in the UK receives exactly the same medical monitoring as a volunteer in Australia (e.g. MRI scans, blood tests, ECG). This is the same as a study that’s open in an NHS clinic as well as a private clinic (like us).
The protocol for the research study is approved by an ethics committee before it’s possible to enrol volunteers. We take patient safety and compliance extremely seriously and follow the standards outlined by the MHRA and CQC closely.
We work with leading pharmaceutical companies across the world and are proud to have received a number of national awards for the exceptional care we provide.
If someone has a diagnosis of Alzheimer’s Disease I would say get in touch with Re:Cognition Health: they are doing excellent work and look after you so well throughout the processStudy Partner of Clinical Trial Volunteer
An individual contribution with a phenomenal global impact
Without inspirational individuals taking part in Alzheimer’s, dementia and memory loss trials, new medications cannot be licensed for global use. This is because the sponsor needs to demonstrate the efficacy and safety of the medication. Even paracetamol went through a clinical trial at one stage!
We do not run phase 1 trials at our clinics and the study medication has been given to humans in previous studies.
Volunteer Opportunities – Potential Benefits
- Study volunteers get early access to new treatments for memory loss and are monitored closely throughout the trial
- Outstanding medical care is provided at no cost, including comprehensive health screens, MRI scans and PET scans
- Avoid lengthy NHS waiting lists and access expert care in a private clinic setting
- Travel expenses are reimbursed for each visit and complimentary refreshments are available
- Prevent the onset of memory problems
- Change the future of Alzheimer’s; help develop dementia syndrome and memory loss treatmentsfor future generations